Scott Greenfeder
Department of Cardiovascular and Metabolic Diseases
Schering-Plough Research Institute
USA
Name/email consistency: high
- Emerging strategies and agents to lower cardiovascular risk by increasing high density lipoprotein cholesterol levels. Greenfeder, S. Curr. Med. Chem. (2009)
- Real-time assay of tryptase release from human umbilical cord blood-derived mast cells. Greenfeder, S., Gilchrest, H., Cheewatrakoolpong, B., Eckel, S., Billah, M., Egan, R.W., Anthes, J.C. BioTechniques (2003)
- New asthma targets: recent clinical and preclinical advances. Greenfeder, S., Anthes, J.C. Curr. Opin. Chem. Biol (2002)
- Tryptase-induced airway microvascular leakage in guinea pigs: involvement of tachykinins and leukotrienes. Greenfeder, S., Sehring, S., McHugh, N., Corboz, M., Rivelli, M., Anthes, J.C., Billah, M., Egan, R.W., Chapman, R.W. Eur. J. Pharmacol. (2001)
- Th2 cytokines and asthma. The role of interleukin-5 in allergic eosinophilic disease. Greenfeder, S., Umland, S.P., Cuss, F.M., Chapman, R.W., Egan, R.W. Respir. Res. (2001)
- The neurokinin-1 and neurokinin-2 receptor binding sites of MDL103,392 differ. Greenfeder, S., Cheewatrakoolpong, B., Billah, M., Egan, R.W., Keene, E., Murgolo, N.J., Anthes, J.C. Bioorg. Med. Chem. (1999)
- Two related neurokinin-1 receptor antagonists have overlapping but different binding sites. Greenfeder, S., Cheewatrakoolpong, B., Anthes, J., Billah, M., Egan, R.W., Brown, J.E., Murgolo, N.J. Bioorg. Med. Chem. (1998)
